(Q37777216)

23 August 2017

1 reference

title

Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression (English)

1 reference

23 August 2017

main subject

irritable bowel syndrome

1 reference

Megan Friedrich

1

1 reference

23 August 2017

Sarah E. Grady

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20678672

15 June 2024

Geoffrey C. Wall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20678672

15 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20678672

15 June 2024

publication date

1 July 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0149291810002298?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

https://api.elsevier.com/content/article/PII:S0149291810002298?httpAccept=text/plain

15 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

15 June 2024

published in

Clinical Therapeutics

1 reference

23 August 2017

volume

32

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

1221-1233

1 reference

Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Medical costs in community subjects with irritable bowel syndrome

15 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Functional bowel disorders

15 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Irritable bowel syndrome, anxiety, and depression: what are the links?

15 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

15 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

The role of serotonin in irritable bowel syndrome: implications for management

15 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Brain research in functional gastrointestinal disorders

15 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Brain-gut interaction in irritable bowel syndrome.

15 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

The enteric nervous system

15 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Serotonin receptor modulators in the treatment of irritable bowel syndrome.

15 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

15 June 2024

Irritable bowel syndrome

12

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Serotonergic modulation of visceral sensation: lower gut.

15 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Emerging treatments for irritable bowel syndrome

15 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Chronic pain and medullary descending facilitation

15 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Fundamentals of neurogastroenterology: basic science

15 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

15 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression

15 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates

15 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

15 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial

15 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study

15 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study

15 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

15 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

15 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents

15 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome

15 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial

15 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Towards positive diagnosis of the irritable bowel

15 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.

15 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Irritable bowel syndrome and mirtazapine

15 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Management of the irritable bowel syndrome

15 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Irritable bowel syndrome: a technical review for practice guideline development

15 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

Treatment of irritable bowel syndrome: a review of randomised controlled trials

15 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.002

15 June 2024

Identifiers

1 reference

23 August 2017

1 reference